Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2014 (2014), Article ID 308732, 6 pages
http://dx.doi.org/10.1155/2014/308732
Research Article

Fusion-Expressed CTB Improves Both Systemic and Mucosal T-Cell Responses Elicited by an Intranasal DNA Priming/Intramuscular Recombinant Vaccinia Boosting Regimen

1Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China
2Institute of Biomedical Science, Fudan University, Shanghai 200032, China

Received 13 November 2013; Accepted 7 March 2014; Published 1 April 2014

Academic Editor: Diane Williamson

Copyright © 2014 Sugan Qiu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Coban, K. Kobiyama, T. Aoshi et al., “Novel strategies to improve DNA vaccine immunogenicity,” Current Gene Therapy, vol. 11, no. 6, pp. 479–484, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. C. O. Elson and W. Ealding, “Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen,” The Journal of Immunology, vol. 133, no. 6, pp. 2892–2897, 1984. View at Google Scholar · View at Scopus
  3. A. D. Wilson, C. J. Clarke, and C. R. Stokes, “Whole cholera toxin and B subunit act synergistically as an adjuvant for the mucosal immune response of mice to keyhole limpet haemocyanin,” The Journal of Immunology, vol. 31, no. 4, pp. 443–451, 1990. View at Google Scholar · View at Scopus
  4. S. J. McKenzie and J. F. Halsey, “Cholera toxin B subunit as a carrier protein to stimulate a mucosal immune response,” The Journal of Immunology, vol. 133, no. 4, pp. 1818–1824, 1984. View at Google Scholar · View at Scopus
  5. H. Cong, M. Zhang, Q. Xin et al., “Compound DNA vaccine encoding SAG1/ SAG3 with A2/B subunit of cholera toxin as a genetic adjuvant protects BALB/c mice against Toxoplasma gondii,” Parasites & Vectors, no. 6, article 63, 2013. View at Google Scholar
  6. K. C. Bagley, G. K. Lewis, and T. R. Fouts, “Adjuvant activity of the catalytic A1 domain of cholera toxin for retroviral antigens delivered by GeneGun,” Clinical and Vaccine Immunology, vol. 18, no. 6, pp. 922–930, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. X. Huang, J. Xu, C. Qiu et al., “Mucosal priming with PEI/DNA complex and systemic boosting with recombinant TianTan vaccinia stimulate vigorous mucosal and systemic immune responses,” Vaccine, vol. 25, no. 14, pp. 2620–2629, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. M. R. Neutra and P. A. Kozlowski, “Mucosal vaccines: the promise and the challenge,” Nature Reviews Immunology, vol. 6, no. 2, pp. 148–158, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Holmgren and C. Czerkinsky, “Mucosal immunity and vaccines,” Nature Medicine, vol. 11, pp. S45–S53, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. M. B. Parr and E. L. Parr, “Vaginal immunity in the HSV-2 mouse model,” International Reviews of Immunology, vol. 22, no. 1, pp. 43–63, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. R. P. Morrison and H. D. Caldwell, “Immunity to murine chlamydial genital infection,” Infection and Immunity, vol. 70, no. 6, pp. 2741–2751, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Sánchez and J. Holmgren, “Cholera toxin: a foe & a friend,” Indian Journal of Medical Research, vol. 133, no. 2, pp. 153–163, 2011. View at Google Scholar · View at Scopus
  13. S. Park, S. Chun, and P. Kim, “Intraperitoneal delivery of cholera toxin B subunit enhances systemic and mucosal antibody responses,” Molecules and Cells, vol. 16, no. 1, pp. 106–112, 2003. View at Google Scholar · View at Scopus